Abstract
Monotherapy with intravenous vinflunine is indicated for the treatment of adults with advanced or metastatic transitional cell carcinoma of the urothelium after failure of a prior platinum-containing regimen. In this patient population, vinflunine added to best supportive care provided a survival advantage over the use of best supportive care alone and, given the nature of the disease, had an acceptable tolerability profile.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
